Physician profile
Serena N Pascal
NPI 1992352728
$426.06
in general payments reported to CMS, 2019-2025
11 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $192 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.07 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $177.56 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $49.39 | 2024-2025 | |
| Optumhealth Care Solutions, LLC | $35.02 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Evofem Biosciences, INC. | $25.58 | 2025 | Solosec, Phexx, Phexxi |
| Mayne Pharma Commercial LLC | $25.22 | 2025 | |
| Millicent US INC | $24.83 | 2024 | Intrarosa |
| Exeltis, USA INC. | $21.52 | 2024 | Slynd |
| Hologic Sales and Service, LLC | $19.46 | 2025 | Acessa Provu System |
| Pfizer INC. | $19.13 | 2024 | |
| Sumitomo Pharma America, INC. | $17.15 | 2025 | Myfembree |
| Aspira Women'S Health INC | $11.20 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Pascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.